Sensus Healthcare, Inc.
SRTS · Surgical & Medical Instruments & Apparatus · 16.5M shares · -0%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: -$23K (gross $300K, SBC $323K)
Reference price $3.33 · est. market cap ~$55M — last insider purchase, 2026-05-12 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Dermatology-radiotherapy device maker with a revenue collapse and losses, cash-rich.
Strengths
- Cash-rich — current ratio 9.7 (90th)
Risks
- Revenue collapse and losses — revenue -34%, net income -216%
- Lumpy capital-equipment sales — per 10-K
- Customer concentration — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Net lossNet loss (net margin -28.1%)
- Auditor changeRecent 8-K item 4.01 8-K ↗
- Customer concentration~58% of revenue from one customer/distributor — 4 million, or 58
- Revenue declineRevenue -31.3% YoY
- Notable holderHeld by 4 notable fund(s): RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, CITADEL ADVISORS LLC +1 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
43.2%
Operating margin
-37.5%
Net margin
-28.1%
Return on equity
-16.0%
Return on assets
-14.6%
Revenue growth (QoQ)
-31.3%
Net-income growth
-216.1%
Current ratio
9.7×
Free cash flow
$332K
EBITDA
-$10M
Tangible book value
$48M
Cash & investments
$22M
Stock comp / revenue
1.1%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-12 | Sachetta Eric | Buy | 1.5K | $3.33 |
| 2026-02-24 | Sachetta Eric | Buy | 2.0K | $3.81 |
| 2025-12-12 | Sardano Michael | Grant | 40K | — |
| 2025-11-21 | Sachetta Eric | Buy | 7.0K | $3.93 |
| 2025-11-18 | Sardano Michael | Buy | 1.0K | $3.80 |
| 2025-11-18 | Sardano Joseph C | Buy | 25K | $4.03 |
| 2025-11-13 | Sachetta Eric | Buy | 2.5K | $4.50 |
| 2025-11-11 | Sardano Michael | Buy | 766 | $4.27 |
| 2025-11-11 | Sardano Michael | Buy | 1.0K | $4.26 |
| 2025-11-11 | Sardano Michael | Buy | 234 | $4.34 |
| 2025-11-11 | Sardano Michael | Buy | 1.0K | $4.26 |
| 2025-11-11 | Sardano Michael | Buy | 766 | $4.27 |
| 2025-11-11 | Sardano Michael | Buy | 234 | $4.24 |
| 2025-11-11 | Sardano Michael | Buy | 1.0K | $4.26 |
| 2025-08-13 | Sardano Michael | Buy | 1.0K | $3.37 |
| 2025-02-10 | Rampolla Javier | Buy | 501 | $5.95 |
| 2025-02-10 | Sardano Michael | Buy | 1.0K | $5.95 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-05 | Material agreementExhibits | filing ↗ |
| 2026-06-02 | Shareholder vote | filing ↗ |
| 2026-05-07 | ResultsExhibits | filing ↗ |
| 2026-02-12 | ResultsExhibits | filing ↗ |
| 2026-01-20 | Auditor changeExhibits | filing ↗ |
| 2026-01-12 | Exec/director changeExhibits | filing ↗ |
| 2025-11-13 | Exec/director changeExhibits | filing ↗ |
| 2025-11-06 | ResultsExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-05 | 2026-06-02 | 0001753926-26-000983 ↗ |
| 8-K | 2026-06-02 | 2026-05-29 | 0001753926-26-000960 ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | 0001753926-26-000845 ↗ |
| 8-K | 2026-05-07 | 2026-05-07 | 0001753926-26-000782 ↗ |
| 10-K | 2026-03-04 | 2025-12-31 | 0001753926-26-000435 ↗ |
| 8-K | 2026-02-12 | 2026-02-12 | 0001753926-26-000315 ↗ |
| 8-K | 2026-01-20 | 2026-01-13 | 0001753926-26-000147 ↗ |
| 8-K | 2026-01-12 | 2026-01-05 | 0001753926-26-000088 ↗ |
| 8-K | 2025-11-13 | 2025-11-10 | 0001753926-25-001772 ↗ |
| 10-Q | 2025-11-12 | 2025-09-30 | 0001753926-25-001745 ↗ |
| 8-K | 2025-11-06 | 2025-11-06 | 0001753926-25-001710 ↗ |
| 10-Q | 2025-08-12 | 2025-06-30 | 0001753926-25-001290 ↗ |